Procept Biorobotics Corp (PRCT) returns
Procept Biorobotics returns over 5 years
$1,000 invested in Procept Biorobotics five years ago was worth $449.33 at the close on October 30, 2026, with dividends reinvested: an average return of -14.8% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +5.4% | — | $1,054 | -0.9% |
| 3 months | +6.7% | — | $1,067 | +2.1% |
| Year to date | -39.0% | — | $610.30 | +11.7% |
| 1 year | -44.2% | — | $558.46 | +12.4% |
| 3 years | -22.9% | -8.3% | $771.39 | +88.5% |
| 5 years | -55.1% | -14.8% | $449.33 | +76.0% |
Procept Biorobotics return by calendar year
| Year | PRCT | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -39.0% | +11.7% | -50.7% |
| 2025 | -60.9% | +17.7% | -78.6% |
| 2024 | +92.1% | +24.9% | +67.2% |
| 2023 | +0.9% | +26.2% | -25.3% |
| 2022 | +66.1% | -18.2% | +84.3% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: PRCT financials
No forecast, no recommendation. This page describes Procept Biorobotics Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.